These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15610905)

  • 1. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
    Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
    Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
    Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
    Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
    Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
    Arch Med Res; 2005; 36(1):87-95. PubMed ID: 15900628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
    Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
    Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Sartor RB; Adam A; Colman RW
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G180-6. PubMed ID: 12065305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis.
    Sainz IM; Isordia-Salas I; Castaneda JL; Agelan A; Liu B; DeLa Cadena RA; Pixley RA; Adam A; Sartor RB; Colman RW
    Arthritis Rheum; 2005 Aug; 52(8):2549-52. PubMed ID: 16059911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and tissue kallikrein in arthritis and inflammatory bowel disease.
    Colman RW
    Immunopharmacology; 1999 Sep; 43(2-3):103-8. PubMed ID: 10596840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Balfour Sartor R; Adam A; Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1895-905. PubMed ID: 12489803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
    Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
    Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis.
    Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW
    Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
    Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
    Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
    Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
    FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.
    DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of plasma kallikrein-kinin system to alleviate renal injury and arthritis symptoms in rats with adjuvant-induced arthritis.
    Zhu J; Wang H; Chen J; Wei W
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):134-148. PubMed ID: 29303013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
    Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
    Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of kallikrein-kinin system in the pathogenesis of bacterial cell wall-induced inflammation and enterocolitis.
    DeLa Cadena RA; Sartor RB; Adam A; Raymond B; Legris F; Colman RW
    Trans Assoc Am Physicians; 1992; 105():229-37. PubMed ID: 1309001
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
    Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
    J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models of inflammatory bowel disease.
    Stadnicki A; Colman RW
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):149-55. PubMed ID: 12894869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.